Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-10

Butein Synergizes with Statin to Upregulate Low-Density Lipoprotein Receptor Through HNF1α -Mediated PCSK9 Inhibition in HepG2 Cells

Jin-Taek Hwang, Hyo Jin Kim, Hyo-Kyoung Choi [...]

Journal of Medicinal Food

Open access

Research article

First published 2020-6

Butanolic Extract of Noni Inhibits Proliferation,Inflammation,and Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Cultured Smooth Muscle Cells

Takanori Matsui, Yuji Ishibashi, Ami Sotokawauchi [...]

Natural Product Communications

Open access

Research article

First published 2020

Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies

Tahir Mahmood, Jessica Minnier, Matthew K Ito [...]

European Journal of Preventive Cardiology

Retricted access

Editorial

First published 2017-9

PCSK9 inhibition in statin-intolerant HeFH patients: What’s new?

Manuela Casula, Angela Pirillo, Giuseppe Danilo Norata [...]

European Journal of Preventive Cardiology

Retricted access

Research article

First published 2025-1

RETRACTED: PCSK9 inhibitor protects against myocardial ischemia-reperfusion injury via inhibiting LRP8/GPX4-mediated ferroptosis

E. Lusha, Ping Zhao

Clinical Hemorheology and Microcirculation

Retricted access

Research article

First published 2016-12

Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis

Zufeng Ding, Shijie Liu, Xianwei Wang [...]

Antioxidants & Redox Signaling

Free access

Research article

First published 2022-9

Regulatory Experience Assessing the Carcinogenic Potential of a Monoclonal Antibody Inhibiting PCSK9,Bococizumab,Including a 2-Year Carcinogenicity Study in Rats

Bernard S. Buetow, Gregg D Cappon, Laura M. Aschenbrenner [...]

International Journal of Toxicology

Free access

Research article

First published 2018-9

Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals

Scott M. Wasserman, Marc S. Sabatine, Michael J. Koren [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Review article

First published 2025

PCSK9 in critical illness – It’s not all about lipids

Emma Crossley, Jonathan A Silversides, Cecilia M O’Kane [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Retricted access

Review article

First published 2019-6

Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents

C Macchi, M Banach, A Corsini [...]

European Journal of Preventive Cardiology

Search results